Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone vs Amlodipine in Hypertensive Striatin Risk Allele Carriers
NCT03683069Phase 4Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Jan 2019
- Primary completion
- Aug 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of eplerenone in hypertension (HTN) (2 arms), sponsored by Brigham and Women's Hospital. Primary endpoint: Systolic /Diastolic Supine Morning Liberal Salt Automated Blood Pressure at 12 weeks. Started Jan 2019; status: completed.
02
Drugs
eplerenone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03683069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03683069.